Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

GlaxoSmithKline Plc's diabetes pill Avandia doesn't 'positively influence' the health of diabetics and contributes to weight gain, swelling, heart risks and broken bones, according to a review of 18 studies. Avandia didn't reduce death, stop new health complications or improve diabetics' quality of life, according to the analysis published in the Cochrane Library. The drug also didn't lower blood sugar better than other diabetes pills


Today in Popular Press...keeping you current

Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products
Boehringer Ingelheim, 10/30/09

Nobel Prize team includes three hospital researchers
American Hospital Association News, 10/14/09

Call for Applications: The Amgen Award for Science Teaching Excellence
Amgen, 11/05/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address